- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07725250
Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk
Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial
This study evaluates a new digital health program that uses artificial intelligence (AI) to help patients lower their blood pressure through personalized lifestyle recommendations. The program collects information about patients' daily habits and blood pressure readings, then uses AI to suggest lifestyle changes that may work best for each person. The study will measure how well this program works across different groups of patients and aims to improve the program design to make it more effective and easier to use. The program will be offered to diverse patients at UC San Diego Health, including people of different ages, genders, races/ethnicities, and economic backgrounds, as part of their regular healthcare services.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Amanda Walker
- Telefoonnummer: 617-588-1445
- E-mail: Alw038@health.ucsd.edu
Studie Contact Back-up
- Naam: Ross Graham
- E-mail: rograham@health.ucsd.edu
Studie Locaties
-
-
California
-
La Jolla, California, Verenigde Staten, 92093
- Werving
- University of California, San Diego
-
Contact:
- Amanda Walker
- Telefoonnummer: 617-588-1445
- E-mail: Alw038@health.ucsd.edu
-
Contact:
- Ross Graham
- E-mail: rograham@health.ucsd.edu
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Stage I-II hypertension (average clinical readings of blood pressure over 140/90)
- Adequate decisional capacity to make a choice about participating in this research study
- Fully ambulatory (not requiring assistive device such as a cane, wheelchair, walker, etc.)
Exclusion Criteria:
- Pregnancy
- Under age 18 years
- Institutionalized individuals who are likely to be vulnerable
- Dependent on supplemental oxygen
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: RCT Arm A: Digital health tool
Participants in this arm will receive the Digital Health Tool intervention. |
Digital health tool of patient-tailored lifestyle recommendations for blood pressure maintenance. Current "simplified" remote patient monitoring program referred to as "P1000." Requires daily blood pressure readings only. |
|
Experimenteel: RCT Arm B.1: Digital health tool + low-intensity recommendations
Participants in this arm will receive the Digital Health Tool and Low-Intensity Recommendation interventions. |
Digital health tool of patient-tailored lifestyle recommendations for blood pressure maintenance. Current "simplified" remote patient monitoring program referred to as "P1000." Requires daily blood pressure readings only. AI-enhanced lifestyle and health recommendations provided weekly. This requires blood pressure readings, as well as passive readings, (e.g. sleep, movement), and a daily questionnaire. |
|
Experimenteel: RCT Arm B.2: Digital health tool + high-intensity recommendations
Participants in this arm will receive the Digital Health Tool and High-Intensity Recommendation interventions. |
Digital health tool of patient-tailored lifestyle recommendations for blood pressure maintenance. Current "simplified" remote patient monitoring program referred to as "P1000." Requires daily blood pressure readings only. AI-enhanced lifestyle and health recommendations provided weekly, plus daily reminders. This requires blood pressure readings, as well as passive readings, (e.g. sleep, movement), and a daily questionnaire. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Systolic blood pressure measurement
Tijdsspanne: 6 months
|
6 months
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Itzik Fadlon, National Bureau of Economic Research, Inc.
- Hoofdonderzoeker: Ming Tai-Seale, University of California, San Diego
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 8577_RCT
- 5P30AG034532 (Subsidie/contract van de Amerikaanse NIH)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
All study data, except for identifiers, will be shared. Before data is shared publicly, all identifiers will be removed in keeping with HIPAA standards (i.e., §164.514(b)1 or (b)2) and the standards of the IRB of Record. Identifiable data will not be shared publicly and will be stored only on secure servers and accessed only by personnel with appropriate training and a legitimate need to know.
IPD-tijdsbestek voor delen
We plan to publicly archive our statistical analysis plan (SAP) and study protocol at ClinicialTrials.gov before performing any data analysis. This will serve both as an ex ante record of the hypotheses to be tested and provide a resource to other researchers interested in implementing similar study designs.
We plan to share the individual participant data (IPD), analytic code, and supporting materials in multiple ways. The resources will be posted to ClinicalTrials.gov by the paper's online publication date or within 12 months of the primary completion date (whichever comes first), in accordance with the NIH Policy on the Dissemination of NIH-Funded Clinical Trial Information (NOT-OD-16-149). We will also catalog public use data and analytic code on the NBER Data Archive (www.nber.org/data/) to encourage its use by the wider community. We expect to receive institutional approval at the appropriate times for all resource sharing.
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- SAP
- ICF
- ANALYTIC_CODE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .